Nathan Dahl
Associate Professor of Pediatrics (Lab-Based · University of Colorado School of Medicine
Credentials: · · · ·
History
- 2016–2017
Pediatric Hematology-Oncology
2009–2013
Research
Targeting IL-6 Is a Potential Treatment for Primary Cystic Craniopharyngioma
Case report · Frontiers in Oncology · 2019 · 69 citations
Senescence Induced by BMI1 Inhibition Is a Therapeutic Vulnerability in H3K27M-Mutant DIPG
Cell Reports · 2020 · 56 citations
Super Elongation Complex as a Targetable Dependency in Diffuse Midline Glioma
Cell Reports · 2020 · First of 14 authors · Corresponding · 42 citations
22 papers
18 papers
10 papers
7 papers
6 papers
- AG
5 papers · 4 as a fellow
- LH
Lindsey Hoffman
4 papers
- CR
3 papers · 3 as a resident
Grants
- 2021–2026
CDK9-Mediated Processive Transcription in H3K27M+ Diffuse Intrinsic Pontine Glioma
National Institute of Neurological Disorders and Stroke · K08
Contact PI · $949.5K · University of Colorado Denver